Lysosomal Storage Diseases Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lysosomal Storage Diseases Market Size Growth Rate by Type: 2018 VS 2022 VS 2032
1.2.2 Enzyme Replacement Therapy
1.2.3 Substrate Reduction Therapy
1.2.4 Cystine Depleting Agents
1.3 Market by Application
1.3.1 Global Lysosomal Storage Diseases Market Share by Application: 2018 VS 2022 VS 2032
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Lysosomal Storage Diseases Market Perspective (2018-2032)
2.2 Lysosomal Storage Diseases Growth Trends by Region
2.2.1 Lysosomal Storage Diseases Market Size by Region: 2018 VS 2022 VS 2032
2.2.2 Lysosomal Storage Diseases Historic Market Size by Region (2018-2023)
2.2.3 Lysosomal Storage Diseases Forecasted Market Size by Region (2023-2032)
2.3 Lysosomal Storage Diseases Market Dynamics
2.3.1 Lysosomal Storage Diseases Industry Trends
2.3.2 Lysosomal Storage Diseases Market Drivers
2.3.3 Lysosomal Storage Diseases Market Challenges
2.3.4 Lysosomal Storage Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lysosomal Storage Diseases Players by Revenue
3.1.1 Global Top Lysosomal Storage Diseases Players by Revenue (2018-2023)
3.1.2 Global Lysosomal Storage Diseases Revenue Market Share by Players (2018-2023)
3.2 Global Lysosomal Storage Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lysosomal Storage Diseases Revenue
3.4 Global Lysosomal Storage Diseases Market Concentration Ratio
3.4.1 Global Lysosomal Storage Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lysosomal Storage Diseases Revenue in 2022
3.5 Lysosomal Storage Diseases Key Players Head office and Area Served
3.6 Key Players Lysosomal Storage Diseases Product Solution and Service
3.7 Date of Enter into Lysosomal Storage Diseases Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lysosomal Storage Diseases Breakdown Data by Type
4.1 Global Lysosomal Storage Diseases Historic Market Size by Type (2018-2023)
4.2 Global Lysosomal Storage Diseases Forecasted Market Size by Type (2023-2032)
5 Lysosomal Storage Diseases Breakdown Data by Application
5.1 Global Lysosomal Storage Diseases Historic Market Size by Application (2018-2023)
5.2 Global Lysosomal Storage Diseases Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Lysosomal Storage Diseases Market Size (2018-2032)
6.2 North America Lysosomal Storage Diseases Market Size by Country (2018-2023)
6.3 North America Lysosomal Storage Diseases Market Size by Country (2023-2032)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Lysosomal Storage Diseases Market Size (2018-2032)
7.2 Europe Lysosomal Storage Diseases Market Size by Country (2018-2023)
7.3 Europe Lysosomal Storage Diseases Market Size by Country (2023-2032)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lysosomal Storage Diseases Market Size (2018-2032)
8.2 Asia-Pacific Lysosomal Storage Diseases Market Size by Country (2018-2023)
8.3 Asia-Pacific Lysosomal Storage Diseases Market Size by Country (2023-2032)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Lysosomal Storage Diseases Market Size (2018-2032)
9.2 Latin America Lysosomal Storage Diseases Market Size by Country (2018-2023)
9.3 Latin America Lysosomal Storage Diseases Market Size by Country (2023-2032)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lysosomal Storage Diseases Market Size (2018-2032)
10.2 Middle East & Africa Lysosomal Storage Diseases Market Size by Country (2018-2023)
10.3 Middle East & Africa Lysosomal Storage Diseases Market Size by Country (2023-2032)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Actelion Pharmaceuticals
11.1.1 Actelion Pharmaceuticals Company Detail
11.1.2 Actelion Pharmaceuticals Business Overview
11.1.3 Actelion Pharmaceuticals Lysosomal Storage Diseases Introduction
11.1.4 Actelion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2018-2023)
11.1.5 Actelion Pharmaceuticals Recent Development
11.2 BioMarin
11.2.1 BioMarin Company Detail
11.2.2 BioMarin Business Overview
11.2.3 BioMarin Lysosomal Storage Diseases Introduction
11.2.4 BioMarin Revenue in Lysosomal Storage Diseases Business (2018-2023)
11.2.5 BioMarin Recent Development
11.3 Genzyme
11.3.1 Genzyme Company Detail
11.3.2 Genzyme Business Overview
11.3.3 Genzyme Lysosomal Storage Diseases Introduction
11.3.4 Genzyme Revenue in Lysosomal Storage Diseases Business (2018-2023)
11.3.5 Genzyme Recent Development
11.4 Takeda
11.4.1 Takeda Company Detail
11.4.2 Takeda Business Overview
11.4.3 Takeda Lysosomal Storage Diseases Introduction
11.4.4 Takeda Revenue in Lysosomal Storage Diseases Business (2018-2023)
11.4.5 Takeda Recent Development
11.5 Alexion Pharmaceuticals
11.5.1 Alexion Pharmaceuticals Company Detail
11.5.2 Alexion Pharmaceuticals Business Overview
11.5.3 Alexion Pharmaceuticals Lysosomal Storage Diseases Introduction
11.5.4 Alexion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2018-2023)
11.5.5 Alexion Pharmaceuticals Recent Development
11.6 Amicus Therapeutics
11.6.1 Amicus Therapeutics Company Detail
11.6.2 Amicus Therapeutics Business Overview
11.6.3 Amicus Therapeutics Lysosomal Storage Diseases Introduction
11.6.4 Amicus Therapeutics Revenue in Lysosomal Storage Diseases Business (2018-2023)
11.6.5 Amicus Therapeutics Recent Development
11.7 Chiesi Farmaceutici
11.7.1 Chiesi Farmaceutici Company Detail
11.7.2 Chiesi Farmaceutici Business Overview
11.7.3 Chiesi Farmaceutici Lysosomal Storage Diseases Introduction
11.7.4 Chiesi Farmaceutici Revenue in Lysosomal Storage Diseases Business (2018-2023)
11.7.5 Chiesi Farmaceutici Recent Development
11.8 Greenovation Biotech And FGK Clinical Research
11.8.1 Greenovation Biotech And FGK Clinical Research Company Detail
11.8.2 Greenovation Biotech And FGK Clinical Research Business Overview
11.8.3 Greenovation Biotech And FGK Clinical Research Lysosomal Storage Diseases Introduction
11.8.4 Greenovation Biotech And FGK Clinical Research Revenue in Lysosomal Storage Diseases Business (2018-2023)
11.8.5 Greenovation Biotech And FGK Clinical Research Recent Development
11.9 Horizon Pharma
11.9.1 Horizon Pharma Company Detail
11.9.2 Horizon Pharma Business Overview
11.9.3 Horizon Pharma Lysosomal Storage Diseases Introduction
11.9.4 Horizon Pharma Revenue in Lysosomal Storage Diseases Business (2018-2023)
11.9.5 Horizon Pharma Recent Development
11.10 Leadiant Biosciences
11.10.1 Leadiant Biosciences Company Detail
11.10.2 Leadiant Biosciences Business Overview
11.10.3 Leadiant Biosciences Lysosomal Storage Diseases Introduction
11.10.4 Leadiant Biosciences Revenue in Lysosomal Storage Diseases Business (2018-2023)
11.10.5 Leadiant Biosciences Recent Development
11.11 Mylan
11.11.1 Mylan Company Detail
11.11.2 Mylan Business Overview
11.11.3 Mylan Lysosomal Storage Diseases Introduction
11.11.4 Mylan Revenue in Lysosomal Storage Diseases Business (2018-2023)
11.11.5 Mylan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Lysosomal Storage Diseases Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2032
Table 2. Key Players of Enzyme Replacement Therapy
Table 3. Key Players of Substrate Reduction Therapy
Table 4. Key Players of Cystine Depleting Agents
Table 5. Global Lysosomal Storage Diseases Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2032
Table 6. Global Lysosomal Storage Diseases Market Size by Region (US$ Million): 2018 VS 2022 VS 2032
Table 7. Global Lysosomal Storage Diseases Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Lysosomal Storage Diseases Market Share by Region (2018-2023)
Table 9. Global Lysosomal Storage Diseases Forecasted Market Size by Region (2023-2032) & (US$ Million)
Table 10. Global Lysosomal Storage Diseases Market Share by Region (2023-2032)
Table 11. Lysosomal Storage Diseases Market Trends
Table 12. Lysosomal Storage Diseases Market Drivers
Table 13. Lysosomal Storage Diseases Market Challenges
Table 14. Lysosomal Storage Diseases Market Restraints
Table 15. Global Lysosomal Storage Diseases Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Lysosomal Storage Diseases Market Share by Players (2018-2023)
Table 17. Global Top Lysosomal Storage Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lysosomal Storage Diseases as of 2022)
Table 18. Ranking of Global Top Lysosomal Storage Diseases Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Lysosomal Storage Diseases Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Lysosomal Storage Diseases Product Solution and Service
Table 22. Date of Enter into Lysosomal Storage Diseases Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Lysosomal Storage Diseases Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Lysosomal Storage Diseases Revenue Market Share by Type (2018-2023)
Table 26. Global Lysosomal Storage Diseases Forecasted Market Size by Type (2023-2032) & (US$ Million)
Table 27. Global Lysosomal Storage Diseases Revenue Market Share by Type (2023-2032)
Table 28. Global Lysosomal Storage Diseases Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Lysosomal Storage Diseases Revenue Market Share by Application (2018-2023)
Table 30. Global Lysosomal Storage Diseases Forecasted Market Size by Application (2023-2032) & (US$ Million)
Table 31. Global Lysosomal Storage Diseases Revenue Market Share by Application (2023-2032)
Table 32. North America Lysosomal Storage Diseases Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Lysosomal Storage Diseases Market Size by Country (2023-2032) & (US$ Million)
Table 34. Europe Lysosomal Storage Diseases Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Lysosomal Storage Diseases Market Size by Country (2023-2032) & (US$ Million)
Table 36. Asia-Pacific Lysosomal Storage Diseases Market Size by Region (2018-2023) & (US$ Million)
Table 37. Asia-Pacific Lysosomal Storage Diseases Market Size by Region (2023-2032) & (US$ Million)
Table 38. Latin America Lysosomal Storage Diseases Market Size by Country (2018-2023) & (US$ Million)
Table 39. Latin America Lysosomal Storage Diseases Market Size by Country (2023-2032) & (US$ Million)
Table 40. Middle East & Africa Lysosomal Storage Diseases Market Size by Country (2018-2023) & (US$ Million)
Table 41. Middle East & Africa Lysosomal Storage Diseases Market Size by Country (2023-2032) & (US$ Million)
Table 42. Actelion Pharmaceuticals Company Detail
Table 43. Actelion Pharmaceuticals Business Overview
Table 44. Actelion Pharmaceuticals Lysosomal Storage Diseases Product
Table 45. Actelion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2018-2023) & (US$ Million)
Table 46. Actelion Pharmaceuticals Recent Development
Table 47. BioMarin Company Detail
Table 48. BioMarin Business Overview
Table 49. BioMarin Lysosomal Storage Diseases Product
Table 50. BioMarin Revenue in Lysosomal Storage Diseases Business (2018-2023) & (US$ Million)
Table 51. BioMarin Recent Development
Table 52. Genzyme Company Detail
Table 53. Genzyme Business Overview
Table 54. Genzyme Lysosomal Storage Diseases Product
Table 55. Genzyme Revenue in Lysosomal Storage Diseases Business (2018-2023) & (US$ Million)
Table 56. Genzyme Recent Development
Table 57. Takeda Company Detail
Table 58. Takeda Business Overview
Table 59. Takeda Lysosomal Storage Diseases Product
Table 60. Takeda Revenue in Lysosomal Storage Diseases Business (2018-2023) & (US$ Million)
Table 61. Takeda Recent Development
Table 62. Alexion Pharmaceuticals Company Detail
Table 63. Alexion Pharmaceuticals Business Overview
Table 64. Alexion Pharmaceuticals Lysosomal Storage Diseases Product
Table 65. Alexion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2018-2023) & (US$ Million)
Table 66. Alexion Pharmaceuticals Recent Development
Table 67. Amicus Therapeutics Company Detail
Table 68. Amicus Therapeutics Business Overview
Table 69. Amicus Therapeutics Lysosomal Storage Diseases Product
Table 70. Amicus Therapeutics Revenue in Lysosomal Storage Diseases Business (2018-2023) & (US$ Million)
Table 71. Amicus Therapeutics Recent Development
Table 72. Chiesi Farmaceutici Company Detail
Table 73. Chiesi Farmaceutici Business Overview
Table 74. Chiesi Farmaceutici Lysosomal Storage Diseases Product
Table 75. Chiesi Farmaceutici Revenue in Lysosomal Storage Diseases Business (2018-2023) & (US$ Million)
Table 76. Chiesi Farmaceutici Recent Development
Table 77. Greenovation Biotech And FGK Clinical Research Company Detail
Table 78. Greenovation Biotech And FGK Clinical Research Business Overview
Table 79. Greenovation Biotech And FGK Clinical Research Lysosomal Storage Diseases Product
Table 80. Greenovation Biotech And FGK Clinical Research Revenue in Lysosomal Storage Diseases Business (2018-2023) & (US$ Million)
Table 81. Greenovation Biotech And FGK Clinical Research Recent Development
Table 82. Horizon Pharma Company Detail
Table 83. Horizon Pharma Business Overview
Table 84. Horizon Pharma Lysosomal Storage Diseases Product
Table 85. Horizon Pharma Revenue in Lysosomal Storage Diseases Business (2018-2023) & (US$ Million)
Table 86. Horizon Pharma Recent Development
Table 87. Leadiant Biosciences Company Detail
Table 88. Leadiant Biosciences Business Overview
Table 89. Leadiant Biosciences Lysosomal Storage Diseases Product
Table 90. Leadiant Biosciences Revenue in Lysosomal Storage Diseases Business (2018-2023) & (US$ Million)
Table 91. Leadiant Biosciences Recent Development
Table 92. Mylan Company Detail
Table 93. Mylan Business Overview
Table 94. Mylan Lysosomal Storage DiseasesProduct
Table 95. Mylan Revenue in Lysosomal Storage Diseases Business (2018-2023) & (US$ Million)
Table 96. Mylan Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lysosomal Storage Diseases Market Share by Type: 2022 VS 2032
Figure 2. Enzyme Replacement Therapy Features
Figure 3. Substrate Reduction Therapy Features
Figure 4. Cystine Depleting Agents Features
Figure 5. Global Lysosomal Storage Diseases Market Share by Application in 2022 & 2032
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Lysosomal Storage Diseases Report Years Considered
Figure 9. Global Lysosomal Storage Diseases Market Size (US$ Million), Year-over-Year: 2018-2032
Figure 10. Global Lysosomal Storage Diseases Market Size, (US$ Million), 2018 VS 2022 VS 2032
Figure 11. Global Lysosomal Storage Diseases Market Share by Region: 2022 VS 2032
Figure 12. Global Lysosomal Storage Diseases Market Share by Players in 2022
Figure 13. Global Top Lysosomal Storage Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lysosomal Storage Diseases as of 2022)
Figure 14. The Top 10 and 5 Players Market Share by Lysosomal Storage Diseases Revenue in 2022
Figure 15. North America Lysosomal Storage Diseases Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 16. North America Lysosomal Storage Diseases Market Share by Country (2018-2032)
Figure 17. United States Lysosomal Storage Diseases Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 18. Canada Lysosomal Storage Diseases Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 19. Europe Lysosomal Storage Diseases Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 20. Europe Lysosomal Storage Diseases Market Share by Country (2018-2032)
Figure 21. Germany Lysosomal Storage Diseases Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 22. France Lysosomal Storage Diseases Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 23. U.K. Lysosomal Storage Diseases Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 24. Italy Lysosomal Storage Diseases Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 25. Russia Lysosomal Storage Diseases Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 26. Nordic Countries Lysosomal Storage Diseases Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 27. Asia-Pacific Lysosomal Storage Diseases Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 28. Asia-Pacific Lysosomal Storage Diseases Market Share by Region (2018-2032)
Figure 29. China Lysosomal Storage Diseases Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 30. Japan Lysosomal Storage Diseases Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 31. South Korea Lysosomal Storage Diseases Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 32. Southeast Asia Lysosomal Storage Diseases Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 33. India Lysosomal Storage Diseases Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 34. Australia Lysosomal Storage Diseases Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 35. Latin America Lysosomal Storage Diseases Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 36. Latin America Lysosomal Storage Diseases Market Share by Country (2018-2032)
Figure 37. Mexico Lysosomal Storage Diseases Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 38. Brazil Lysosomal Storage Diseases Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 39. Middle East & Africa Lysosomal Storage Diseases Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 40. Middle East & Africa Lysosomal Storage Diseases Market Share by Country (2018-2032)
Figure 41. Turkey Lysosomal Storage Diseases Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 42. Saudi Arabia Lysosomal Storage Diseases Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 43. Actelion Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Diseases Business (2018-2023)
Figure 44. BioMarin Revenue Growth Rate in Lysosomal Storage Diseases Business (2018-2023)
Figure 45. Genzyme Revenue Growth Rate in Lysosomal Storage Diseases Business (2018-2023)
Figure 46. Takeda Revenue Growth Rate in Lysosomal Storage Diseases Business (2018-2023)
Figure 47. Alexion Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Diseases Business (2018-2023)
Figure 48. Amicus Therapeutics Revenue Growth Rate in Lysosomal Storage Diseases Business (2018-2023)
Figure 49. Chiesi Farmaceutici Revenue Growth Rate in Lysosomal Storage Diseases Business (2018-2023)
Figure 50. Greenovation Biotech And FGK Clinical Research Revenue Growth Rate in Lysosomal Storage Diseases Business (2018-2023)
Figure 51. Horizon Pharma Revenue Growth Rate in Lysosomal Storage Diseases Business (2018-2023)
Figure 52. Leadiant Biosciences Revenue Growth Rate in Lysosomal Storage Diseases Business (2018-2023)
Figure 53. Mylan Revenue Growth Rate in Lysosomal Storage Diseases Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Industry Market Size
